About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis

Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis

NCT00670202·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Brigham and Women's Hospital

With

Doris Duke Charitable Foundation

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Subjects with \>= 70% carotid stenosis (unilateral or bilateral) who are scheduled to undergo elective carotid endarterectomy
Age \>= 18 years
Agreement of the operating surgeon for patient to participate

You may not be if

Surgery scheduled \< 14 days after randomization
Pregnancy
ALT, GGT \> 3x upper limit of normal (ULN)
Creatinine \> 3.5 mg/dL
Prior intolerance to statins
Reluctance to add or change dosage of statin therapy during study

The record

StatusTerminated

PhasePhase 2

Taking part2

StartedMar 2008

UpdatedMar 29, 2017

Conditions

Carotid Stenosis

Where1

Brigham and Women's Hospital
Boston, Massachusetts, United States